2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid

• ChemBase编号: 129712
• 分子式: C26H45NO6S
• 平均质量: 499.7036
• 单一同位素质量: 499.29675917
• SMILES: O=S(=O)(O)CCNC(=O)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](O)C[C@@H]2C[C@H](O)CC[C@]12C)C
• Canonical SMILES: O[C@@H]1CC[C@]2([C@@H](C1)C[C@H]([C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)NCCS(=O)(=O)O)C)C)O)C
• InChI: InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1
• InChIKey: BHTRKEVKTKCXOH-BJLOMENOSA-N

名称和登记号

名称

• IUPAC标准名: 2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^2,^7.0^1^1,^1^5]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid
• IUPAC传统名: taurochenodeoxycholate
• 别名: 2-[[(3α,5β,7α)-3,7-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic Acid Sodium Salt; N-(3α,7α-dihydroxy-5β-cholan-24-oyl)taurine Sodium Salt; 12-Deoxycholyltaurine Sodium Salt; 12-Desoxycholyltaurine Sodium Salt; 3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide; Chenodeoxycholyltaurine Sodium Salt; Chenyltaurine Sodium Salt; Taurochenodesoxycholic Acid Sodium Salt; Taurochenodeoxycholic Acid Sodium Salt; 12-Deoxycholyltaurine; 12-Desoxycholyltaurine; Chenodeoxycholyltaurine; Chenyltaurine; Taurochenodeoxycholic acid

登记号

• CAS号: 516-35-8
• PubChem SID: 162224001
• PubChem CID: 387316
• CHEBI ID: 16525
• CHEMBL: 185878
• Chemspider ID: 343282
• 维基百科标题: Taurochenodeoxycholic_acid

理论计算性质

• Acid pKa: -0.99043494
• 质子受体: 6
• 质子供体: 4
• LogD (pH = 5.5): -0.22602968
• LogD (pH = 7.4): -0.22606862
• Log P: 0.80769014
• 摩尔折射率: 130.679 cm^3
• 极化性: 52.81067 Å^3
• 极化表面积: 123.93 Å^2
• 可自由旋转的化学键: 7
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - T008130

Taurochenodeoxycholic Acid is a bile acid conjugate and metabolite Taurolithocholic Acid (T009100) with antiinflammatory activity. Taurochenodeoxycholic Acid has been shown to inhibit hepatocyte apoptosis through suppression of Bid translocation to mitoch

参考文献

• Emerman, S. et al.: J. Biol. Chem., 242, 661 (1967)
• Takikawa, Y. et al.: Falk Symp., 120, 249 (1967)
• Li, P. et al.: Zhong. Shour. Xue., 28, 1317 (1967)